Beta Bionics officer proposes $7.41K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Beta Bionics, Inc. officer Mark Hopman filed notice of a proposed sale of 451 common shares, with an aggregate market value of $7,405.42 and an approximate sale date of November 16, 2026. The notice lists acquisition of 451 shares from the issuer through a cash-paid stock-option exercise dated November 16, 2026, and gives June 10, 2026 as the Rule 10b5-1 plan adoption or instruction date.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Exercise of Stock Options financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Does the BBNX Form 144 include earlier sales by Mark Hopman?
AI-generated analysis. How Rhea-AI works. Not financial advice.